Literature DB >> 17209100

High hopes and automatic escalators: a critique of some new arguments in bioethics.

S Holm1, T Takala.   

Abstract

Two protechnology arguments, the "hopeful principle" and the "automatic escalator", often used in bioethics, are identified and critically analysed in this paper. It is shown that the hopeful principle is closely related to the problematic precautionary principle, and the automatic escalator argument has close affinities to the often criticised empirical slippery slope argument. The hopeful principle is shown to be really hopeless as an argument, and automatic escalator arguments often lead nowhere when critically analysed. These arguments should therefore only be used with great caution.

Mesh:

Year:  2007        PMID: 17209100      PMCID: PMC2598075          DOI: 10.1136/jme.2006.016477

Source DB:  PubMed          Journal:  J Med Ethics        ISSN: 0306-6800            Impact factor:   2.903


  8 in total

1.  Genetic engineering and the risk of harm.

Authors:  M Häyry; T Takala
Journal:  Med Health Care Philos       Date:  1998

2.  Extending human lifespan and the precautionary paradox.

Authors:  John Harris; Søren Holm
Journal:  J Med Philos       Date:  2002-06

3.  Implications of nanotechnology applications: using genetics as a lesson.

Authors:  Fiona N Moore
Journal:  Health Law Rev       Date:  2002

4.  Scientific research is a moral duty.

Authors:  John Harris
Journal:  J Med Ethics       Date:  2005-04       Impact factor: 2.903

5.  Precaution and solidarity.

Authors:  Matti Häyry
Journal:  Camb Q Healthc Ethics       Date:  2005       Impact factor: 1.284

6.  Rethinking research ethics.

Authors:  Rosamond Rhodes
Journal:  Am J Bioeth       Date:  2005       Impact factor: 11.229

7.  Human genetic enhancements: a transhumanist perspective.

Authors:  Nick Bostrom
Journal:  J Value Inq       Date:  2003

8.  The embryonic stem cell lottery and the cannibalization of human beings.

Authors:  Julian Savulescu
Journal:  Bioethics       Date:  2002-11       Impact factor: 1.898

  8 in total
  3 in total

1.  When to wait for more evidence? Real options analysis in proton therapy.

Authors:  Janneke P C Grutters; Keith R Abrams; Dirk de Ruysscher; Madelon Pijls-Johannesma; Hans J M Peters; Eric Beutner; Philippe Lambin; Manuela A Joore
Journal:  Oncologist       Date:  2011-12-06

2.  The use of empirical evidence in formulating reproductive policy advice and policy.

Authors:  Søren Holm; Thomas Ploug
Journal:  Monash Bioeth Rev       Date:  2015-03

3.  The ethics of 'public understanding of ethics'--why and how bioethics expertise should include public and patients' voices.

Authors:  Silke Schicktanz; Mark Schweda; Brian Wynne
Journal:  Med Health Care Philos       Date:  2012-05
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.